Clinical & Medical Biochemistry

Impact of Protein Tyrosine Nitration on Signal Transduction Pathways and its Contributions to Cancer Development and Progression

Claude Darluc^* Department of Molecular Biology, University of Paris, Paris, France
^*Correspondence: Claude Darluc, Department of Molecular Biology, University of Paris, Paris, France, Email:

Received: 03-Jul-2023, Manuscript No. CMBO-23-22623; Editor assigned: 07-Jul-2023, Pre QC No. CMBO-23-22623 (PQ); Reviewed: 20-Jul-2023, QC No. CMBO-23-22623; Revised: 27-Jul-2023, Manuscript No. CMBO-23-22623 (R); Published: 03-Aug-2023, DOI: 10.35841/2471-2663.23.9.178

Description

Post-Translational Modifications (PTMs) play a fundamental role in regulating protein function and cellular signaling pathways. Among these PTMs, protein tyrosine nitration has emerged as a dynamic and reversible modification that exerts significant influence on cell signaling processes [1]. Nitration involves the addition of a nitro group (NO ) -to the aromatic ring of tyrosine residues within proteins. While protein tyrosine phosphorylation has long been recognized as a key regulatory event in cell signaling, protein tyrosine nitration has gained increasing attention for its roles in modulating signal transduction pathways and contributing to the pathogenesis of various diseases, including cancer [2].

Protein tyrosine nitration is a complex PTM that involves the generation of Reactive Nitrogen Species (RNS), such as peroxynitrite (ONOO-), through the reaction between nitric oxide (NO) and superoxide anion (O )- [3]. Peroxynitrite serves as a potent nitrating agent that can modify tyrosine residues in proteins, leading to altered protein function [4]. Nitration can impact protein conformation, activity, stability, and interactions with other molecules, thereby influencing cellular processes.

The process of protein tyrosine nitration is regulated by various factors, including the local concentration of NO and O -, the presence of metal ions, and the accessibility of tyrosine residues within proteins [5]. Enzymatic mechanisms, such as those involving Myeloperoxidase (MPO) and eosinophil peroxidase, can also contribute to protein tyrosine nitration.

Protein tyrosine nitration can modulate cell signaling pathways by affecting protein-protein interactions, enzyme activity, and protein turnover [6]. Notably, tyrosine nitration can influence the activation and function of signaling molecules, including kinases, phosphatases, transcription factors, and receptors. Additionally, protein nitration can impact the assembly and stability of signaling complexes, thereby altering the dynamics of cellular responses.

One key example of protein tyrosine nitration in cell signaling is the modulation of Nitric Oxide Synthase (NOS) activity. Nitration of specific tyrosine residues within NOS can affect its enzymatic activity and NO production, leading to downstream effects on vasodilation and other physiological processes [7]. Emerging evidence suggests that protein tyrosine nitration plays a multifaceted role in cancer development and progression. Increased levels of oxidative stress and the generation of RNS, including peroxynitrite, are commonly observed in cancer cells [8].

Protein tyrosine nitration resulting from oxidative stress can impact cellular processes, including DNA damage repair, apoptosis, and cell proliferation [9]. Protein tyrosine nitration can influence various signaling pathways associated with cancer, including those involved in cell survival, proliferation, angiogenesis, and metastasis [10]. Nitration-mediated modifications of signaling molecules can lead to dysregulated cellular responses. Protein tyrosine nitration can affect the immune response within the tumor microenvironment. Nitration of immune-related proteins may influence immune cell function, tumor infiltration, and immune evasion mechanisms.

Nitration can impact the extracellular matrix, promoting changes in tumor-stroma interactions, angiogenesis, and tissue remodeling that support tumor growth and dissemination. Nitration of p53, a key tumor suppressor protein, can affect its stability, DNA-binding capacity, and transcriptional activity. These modifications may contribute to the dysregulation of cell cycle control and apoptosis. Nitration of Epidermal Growth Factor Receptor (EGFR) can impact its activation and downstream signaling, influencing cell proliferation and survival pathways that contribute to tumor growth.

Nitration of NF-κB, a transcription factor involved in inflammation and immune responses, can influence its nuclear translocation and target gene expression, potentially affecting tumor-promoting processes. Nitration of Matrix Metalloproteinase (MMPs) can influence their activity and substrate specificity, impacting extracellular matrix remodeling substrate specificity, impacting extracellular matrix remodeling and facilitating tumor invasion and metastasis. The emerging understanding of protein tyrosine nitration's role in cancer presents novel therapeutic opportunities. Targeting specific nitrated proteins or modulating the balance between nitrating and denitrating processes could potentially impact cancer progression. Furthermore, the development of strategies to selectively target nitrated proteins within tumors has the potential to provide precision medicine approaches. However, understanding the complicated connection between protein tyrosine nitration, cell signalling, and cancer biology remains unresolved.

Conclusion

Protein tyrosine nitration has emerged as a significant player in cell signaling and cancer biology. Through its influence on protein function, protein tyrosine nitration can impact various signaling pathways, contributing to cancer development and progression. Discovering the complexities of protein tyrosine nitration in cancer will probably lead to new opportunities for enhancing cancer detection, therapy, and patient outcomes as the research continues to develop.

References

1. Zhu P, Nguyen KT, Estelle AB, Sluchanko NN, Mehl RA, Cooley RB. Genetic encoding of 3‐nitro‐tyrosine reveals the impacts of 14‐3‐3 nitration on client binding and dephosphorylation. Protein Sci. 2023;32(3):e4574.

   [Crossref] [Google Scholar] [PubMed]

2. Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-592.

   [Crossref] [Google Scholar] [PubMed]

3. Cheng Y, Qi J, Liu K, Zhou C, Wang W, Zuo Y, et al. Characterization of a novel affinity binding ligand for tyrosine nitrated peptides from a phage-displayed peptide library. Talanta. 2022;241:123225.

   [Crossref] [Google Scholar] [PubMed]

4. Wu Q, Li L, Miao C, Hasnat M, Sun L, Jiang Z, Zhang L. Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2/STAT3/NOX1-mediated ROS production. Cell Death Dis. 2022;13(4):341.

   [Crossref] [Google Scholar] [PubMed]

5. Jandy M, Noor A, Nelson P, Dennys CN, Karabinas IM, Pestoni JC, et al. Peroxynitrite nitration of Tyr 56 in Hsp90 induces PC12 cell death through P2X7R-dependent PTEN activation. Redox Biol. 2022;50:102247.

   [Crossref] [Google Scholar] [PubMed]

6. Powell LE, Foster PA. Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy. Cancer Med. 2021;10(8):2812-2825.

   [Crossref] [Google Scholar] [PubMed]

7. Nilamyani AN, Auliah FN, Moni MA, Shoombuatong W, Hasan MM, Kurata H. PredNTS: Improved and robust prediction of nitrotyrosine sites by integrating multiple sequence features. Int J Mol Sci. 2021;22(5):2704.

   [Crossref] [Google Scholar] [PubMed]

8. Zheng Z, Guo X, Yu M, Wang X, Lu H, Li F, et al. Identification of human IDO1 enzyme activity by using genetically encoded nitrotyrosine. Chembiochem. 2020;21(11):1593-1596.

   [Crossref] [Google Scholar] [PubMed]

9. Pottier C, Fresnais M, Gilon M, Jérusalem G, Longuespée R, Sounni NE. Tyrosine kinase inhibitors in cancer: Breakthrough and challenges of targeted therapy. Cancers. 2020;12(3):731.

   [Crossref] [Google Scholar] [PubMed]

10. Law AM, Valdes-Mora F, Gallego-Ortega D. Myeloid-derived suppressor cells as a therapeutic target for cancer. Cells. 2020;9(3):561.

    [Crossref] [Google Scholar] [PubMed]